Pawlotsky JM, et al. Gastroenterology. 2016
DOI: http://dx.doi.org/10.1053/j.gastro.2016.08.043
Publication stage: In Press Uncorrected Proof
Published online: August 30, 2016
Much has been written about the “hepatitis C virus (HCV) drug revolution.” For an individual who started to work on the newly discovered HCV in 1990, at the time happy to describe rates of sustained virologic response (SVR) on the order of 6% with standard interferon (IFN)-α administered 3 times per week for 6 months,1 the current HCV treatment landscape could look miraculous. It is simply the result of an enormous intellectual, scientific, and financial effort of the publicly funded academic and the industrial sectors to solve a major public health problem, building on the experience accumulated in the fight against the human immunodeficiency virus.
No comments:
Post a Comment